Europe Cell Expansion Market was worth USD 2.09 billion in 2016 and is projected to be growing at a CAGR of 18.3%, to touch USD 4.85 billion by 2021.
- Advertising -
The process of cultivating, growing and using stem cells, involves the two vital components of division and expansion. Without the process of cell expansion, a dividing cell is just further divided into smaller and smaller elements.
The essential environment for stem cell expansion is sustained by a mixture of various media, reagents and supplements and may also comprise the involvement of healthy feeder populations or conditioned mechanisms taken off feeder cells.
The growth of the Europe Cell Expansion Market is mainly driven by factors such as the increasing demand for regenerative medicines that provide swift results and have high compatibility with patients.
- Advertising -
Furthermore, increasing incidence of chronic diseases, rising private sector investments for the development of cell-based products and the growing number of Goods Manufacturing Practice (GMP) certifications of production facilities, supplemented by rising governmental investment support are among the other forces driving market growth in North America. However, requirement of skilled workforce and high-tech instrumentation are the major restraints of market growth.
Full report at: www.marketdataforecast.com/market-…sion-market-2665/
The Europe Cell Expansion Market is segmented on the basis of Product, Cell Type, Application, End User and Geography. Based on Product, the Cell Expansion market is divided into Instruments, Consumables and Disposables.
Consumables include reagents, media and serum, and disposables. The instruments segment consists of cell expansion supporting equipment, bioreactors, and automated cell expansion systems.
The cell expansion supporting equipment segments is segmented into flow cytometer, centrifuges, cell counter, and other supporting equipment. Bioreactors are further classified into micro-carrier bioreactors and perfusion/hollow fibre reactors.
Disposables are further classified into tissue culture flasks, bioreactor accessories, and other disposables. On the basis of cell type the market is segmented into Human Cells and Animal Stem Cells.
The human cells segment is further divided into Human Differentiated stem cells and Human stem cells, with the human stem cells segment further categorised into embryonic stem cells, adult stem cells and induced pluripotent stem cells. By Application, the cell expansion market is categorised into Regenerative Medicine and Stem Cell Research, and Cancer and Cell Based Research.
On the basis of End User, the market is distributed among hospitals, biotech and pharma companies, and academic and research institutes.
The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. Europe holds the second position in terms of market share globally.
There is potential for market growth due to the presence of some untapped markets coupled with the rising frequency of chronic ailments. Increasing private sector investments by key companies to increase RandD to expand market margins in the region are set to further set to augment market growth in the European region.
The significant players in the Europe Cell Expansion Market are Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc.
(U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: